Back to search
FDAFDA · Food and drugs·Recall number D-0566-2023

Advil Liqui-Gels Solubilized Ibuprofen Capsules, 200 mg Pain Reliever/Fever Reducer (NSAID) a) 20-count Liquid Filled Capsule bottles; b) 40-count Liquid Filled Capsule bottles.

Published May 10, 2023 · Recall initiated: March 31, 2023

Summary

FDA records drug Class II recall D-0566-2023, published May 10, 2023 and initiated March 31, 2023. Recalling firm: Family Dollar Stores, Llc.; Status: Ongoing; Reported quantity: Pending; Lot: SKUs a) 0999841; b) 0916071 stored and distributed from DCs 07/28/2022 through 03/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviation: product outside labeled storage temperature requirements.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Family Dollar Stores, Llc.
Distributor
Nationwide within the United States
Lot
SKUs a) 0999841; b) 0916071 stored and distributed from DCs 07/28/2022 through 03/31/2023.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Advil Liqui-Gels Solubilized Ibuprofen Capsules, 200 mg Pain Reliever/Fever Reducer (NSAID) a) 20-count Liquid Filled Capsule bottles; b) 40-count Liquid Filled Capsule bottles. recalled?

Yes. FDA published recall D-0566-2023 on May 10, 2023. Reported hazard: CGMP deviation: product outside labeled storage temperature requirements.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit